• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Convalescent plasma therapy for persistent hepatitis E virus infection.

作者信息

Ankcorn Michael, Gallacher Jennifer, Ijaz Samreen, Taha Yusri, Harvala Heli, Maclennan Sheila, Thomson Emma C, Davis Chris, Singer Joshua B, da Silva Filipe Ana, Smollett Katherine, Niebel Marc, Semple Malcolm G, Tedder Richard S, McPherson Stuart

机构信息

Blood Borne Virus Unit, Virus Reference Department, National Infection Service, Public Health England, Colindale, London, UK; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.

Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.

出版信息

J Hepatol. 2019 Aug;71(2):434-438. doi: 10.1016/j.jhep.2019.04.008. Epub 2019 May 8.

DOI:10.1016/j.jhep.2019.04.008
PMID:31075322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7126959/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ad/7126959/17b7b660f412/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ad/7126959/0cc1cc9ea612/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ad/7126959/17b7b660f412/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ad/7126959/0cc1cc9ea612/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ad/7126959/17b7b660f412/gr2_lrg.jpg

相似文献

1
Convalescent plasma therapy for persistent hepatitis E virus infection.康复期血浆疗法治疗持续性戊型肝炎病毒感染
J Hepatol. 2019 Aug;71(2):434-438. doi: 10.1016/j.jhep.2019.04.008. Epub 2019 May 8.
2
[Diagnostic tests: Hepatitis E viral marker].[诊断检测：戊型肝炎病毒标志物]
Nihon Rinsho. 2005 Jul;63 Suppl 7:421-3.
3
Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States.慢性戊型肝炎病毒感染：美国诊断与识别面临的挑战
J Clin Gastroenterol. 2015 Jan;49(1):86-8. doi: 10.1097/MCG.0000000000000082.
4
Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.在法国免疫功能低下人群的队列中，戊型肝炎病毒抗体和 RNA 基因组的流行率。
J Clin Virol. 2012 Apr;53(4):346-9. doi: 10.1016/j.jcv.2012.01.001. Epub 2012 Jan 30.
5
Transfusion-transmitted hepatitis E in Germany, 2013.德国 2013 年经输血传播的戊型肝炎。
Euro Surveill. 2014 May 29;19(21):20812. doi: 10.2807/1560-7917.es2014.19.21.20812.
6
[Hepatitis E viral markers].[戊型肝炎病毒标志物]
Nihon Rinsho. 2010 Jun;68 Suppl 6:458-61.
7
Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso.布基纳法索瓦加杜古献血者中戊型肝炎病毒的流行情况
Emerg Infect Dis. 2016 Apr;22(4):755-7. doi: 10.3201/eid2204.151728.
8
Hepatitis E virus and blood donors in Germany.德国的戊型肝炎病毒与献血者。
Vox Sang. 2010 Apr;98(3 Pt 2):479. doi: 10.1111/j.1423-0410.2009.01258.x. Epub 2010 Feb 2.
9
Recurrent Chronic HEV in Severe Combined Immunodeficiency.严重联合免疫缺陷中的复发性慢性戊型肝炎病毒感染
J Clin Immunol. 2021 Jul;41(5):1103-1105. doi: 10.1007/s10875-021-00999-4. Epub 2021 Feb 22.
10
Hepatitis E virus outbreak in monkey facility, Japan.日本猴设施中的戊型肝炎病毒暴发。
Emerg Infect Dis. 2012 Dec;18(12):2032-4. doi: 10.3201/eid1812.120884.

引用本文的文献

1
Can Adoptive Immunotherapy With Hepatitis E Virus (HEV)-Specific T Cells Address the Unmet Need in Refractory Chronic HEV Infection?采用戊型肝炎病毒（HEV）特异性T细胞的过继性免疫疗法能否满足难治性慢性戊型肝炎感染中未被满足的需求？
Open Forum Infect Dis. 2025 May 27;12(5):ofaf231. doi: 10.1093/ofid/ofaf231. eCollection 2025 May.
2
Pathogenesis, Diagnosis, and Treatment of Infectious Rhinosinusitis.感染性鼻-鼻窦炎的发病机制、诊断与治疗
Microorganisms. 2024 Aug 16;12(8):1690. doi: 10.3390/microorganisms12081690.
3
Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A Review.

本文引用的文献

1
GLUE: a flexible software system for virus sequence data.GLUE：一个用于病毒序列数据的灵活软件系统。
BMC Bioinformatics. 2018 Dec 18;19(1):532. doi: 10.1186/s12859-018-2459-9.
2
Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.戊型肝炎病毒治疗和利巴韦林治疗：无应答的病毒机制。
Curr Opin Virol. 2018 Oct;32:80-87. doi: 10.1016/j.coviro.2018.10.001. Epub 2018 Oct 29.
3
Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products.
新型冠状病毒肺炎的临床特征、诊断和治疗：综述。
Curr Med Sci. 2023 Dec;43(6):1066-1074. doi: 10.1007/s11596-023-2797-3. Epub 2023 Oct 14.
4
Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review.冠状病毒病（COVID-19）的病理生理学和临床管理：小型综述。
Front Immunol. 2023 Aug 14;14:1116131. doi: 10.3389/fimmu.2023.1116131. eCollection 2023.
5
Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection.来迪派韦/索磷布韦与利巴韦林联合治疗对利巴韦林耐药的持续性戊型肝炎病毒感染
IDCases. 2023 Mar 6;32:e01741. doi: 10.1016/j.idcr.2023.e01741. eCollection 2023.
6
Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics.新型冠状病毒病 2019（COVID-19）：SARS-CoV-2 的生物物理和生物化学方面以及一般特征。
Prog Biophys Mol Biol. 2021 Sep;164:3-18. doi: 10.1016/j.pbiomolbio.2021.05.007. Epub 2021 May 24.
7
Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.CD8+ T 细胞耗竭恒河猴体内戊型肝炎病毒感染的清除。
J Hepatol. 2021 Sep;75(3):557-564. doi: 10.1016/j.jhep.2021.04.036. Epub 2021 May 4.
8
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.新冠病毒治疗和诊断方法的最新进展。
AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2.
9
Novel Antiviral Strategies in the Treatment of COVID-19: A Review.治疗新冠肺炎的新型抗病毒策略：综述
Microorganisms. 2020 Aug 20;8(9):1259. doi: 10.3390/microorganisms8091259.
10
Immunoglobulin fragment F(ab') against RBD potently neutralizes SARS-CoV-2 in vitro.针对 RBD 的免疫球蛋白 F(ab') 片段在体外有力地中和了 SARS-CoV-2。
Antiviral Res. 2020 Oct;182:104868. doi: 10.1016/j.antiviral.2020.104868. Epub 2020 Jul 10.
抗体缺陷患者中不存在持续性戊型肝炎病毒感染与从免疫球蛋白产品中转移抗原中和抗体有关。
J Infect Dis. 2019 Jan 7;219(2):245-253. doi: 10.1093/infdis/jiy504.
4
Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.ORF2 编码的分泌型蛋白在戊型肝炎病毒感染中的起源、抗原性和功能。
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4773-4778. doi: 10.1073/pnas.1721345115. Epub 2018 Apr 18.
5
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.埃博拉病毒病患者输注恢复期血浆后病毒载量和抗埃博拉病毒抗体水平的变化。
J Infect Dis. 2018 Jul 13;218(4):555-562. doi: 10.1093/infdis/jiy199.
6
EASL Clinical Practice Guidelines on hepatitis E virus infection.欧洲肝脏研究学会（EASL）丙型肝炎病毒感染临床实践指南
J Hepatol. 2018 Jun;68(6):1256-1271. doi: 10.1016/j.jhep.2018.03.005. Epub 2018 Mar 31.
7
Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.固相 ELISA 检测戊型肝炎病毒抗原反应的特异性确认可提高检测方法的实用性。
J Virol Methods. 2018 Feb;252:42-48. doi: 10.1016/j.jviromet.2017.11.007. Epub 2017 Nov 20.
8
Hepatitis E virus infection.戊型肝炎病毒感染。
Nat Rev Dis Primers. 2017 Nov 16;3:17086. doi: 10.1038/nrdp.2017.86.
9
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.戊型肝炎病毒生命周期和 ORF2 衣壳蛋白 3 种形式的鉴定。
Gastroenterology. 2018 Jan;154(1):211-223.e8. doi: 10.1053/j.gastro.2017.09.020. Epub 2017 Sep 25.
10
Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.通过细胞外泌体途径释放的准包膜戊型肝炎病毒颗粒的特征分析。
J Virol. 2017 Oct 27;91(22). doi: 10.1128/JVI.00822-17. Print 2017 Nov 15.